Article Details
Retrieved on: 2021-03-10 17:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... to the manufacturing of nucleic acids, and now is set to manufacture the mRNA and bulk drug product of CureVac's vaccine candidate CVnCoV.
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here